Top

Osteoporosis International

Published in:

01-08-2016 | Original Article

Quality of life, resource use, and costs related to hip fracture in Estonia

Authors: M. Jürisson, H. Pisarev, J. Kanis, F. Borgström, A. Svedbom, R. Kallikorm, M. Lember, A. Uusküla

Published in: Osteoporosis International | Issue 8/2016

Abstract

Summary

We assessed the impact of hip fracture on health-related quality of life (HRQoL) and costs in Estonia. The mean 18-month HRQoL loss in quality adjusted life years (QALY) was estimated at 0.31, and the average cumulative cost from a societal perspective was 8146 euros per hip fracture patient.

Introduction

The aim of this study is to estimate the impact of hip fracture on HRQoL, resource consumption, and cost over 18 months after the fracture among individuals aged over 50 in Estonia.

Methods

A cohort of 205 hip fracture patients ≥50 years was followed up for 18 months. HRQoL was estimated before fracture (recall), after fracture, and at 4, 12, and 18 months using the EQ-5D instrument. Health care utilization and costs were obtained from a public health insurance fund database; social, informal, and indirect costs were estimated using patient-reported data.

Results

Hip fracture resulted in the mean 18-month HRQoL loss of 0.31 QALYs. The mean 18-months cumulative cost of hip fracture from a societal perspective was estimated at 8146 (95 % CI 6236–10717) euros per patient. Most of the cost was related to health care (56 %) and informal care (33 %), while social care contributed only 5 %. Utilization of outpatient rehabilitation and nursing care was low (8 % of patients).

Conclusions

The impact of hip fracture on HRQoL and cost was substantial. Despite appropriate inpatient care, utilization of rehabilitation, nursing care, and social care were low and potentially insufficient to meet the needs of patients with low HRQoL. The shortfall may partially explain a remarkably high use of informal care.

Available only for authorised users

Melton LJ (2003) Adverse outcomes of osteoporotic fractures in the general population. J Bone Miner Res 18:1139–1141. doi:10.1359/jbmr.2003.18.6.1139 CrossRefPubMed

Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726–1733. doi:10.1007/s00198-006-0172-4 CrossRefPubMed

Johnell O, Kanis JA, Odén A et al (2004) Mortality after osteoporotic fractures. Osteoporos Int 15:38–42. doi:10.1007/s00198-003-1490-4 CrossRefPubMed

Johnell O, Kanis JA (2005) Epidemiology of osteoporotic fractures. Osteoporos Int 16(Suppl 2):S3–S7. doi:10.1007/s00198-004-1702-6 CrossRefPubMed

Abrahamsen B, van Staa T, Ariely R et al (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20:1633–1650. doi:10.1007/s00198-009-0920-3 CrossRefPubMed

Hernlund E, Svedbom A, Ivergård M et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136. doi:10.1007/s11657-013-0136-1 CrossRefPubMedPubMedCentral

Borgstrom F, Lekander I, Ivergard M et al (2013) The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)—quality of life during the first 4 months after fracture. Osteoporos Int 24:811–823. doi:10.1007/s00198-012-2240-2 CrossRefPubMed

Borgström F, Sobocki P, Ström O, Jönsson B (2007) The societal burden of osteoporosis in Sweden. Bone 40:1602–1609. doi:10.1016/j.bone.2007.02.027 CrossRefPubMed

Cheng S, Levy A, Lefaivre K (2011) Geographic trends in incidence of hip fractures: a comprehensive literature review. Osteoporos Int 22:2575–2586. doi:10.1007/s00198-011-1596-z CrossRefPubMed

10.

Odén A, McCloskey EV, Kanis JA et al (2015) Burden of high fracture probability worldwide: secular increases 2010-2040. Osteoporos Int 26:2243–2248. doi:10.1007/s00198-015-3154-6 CrossRefPubMed

11.

Ström O, Borgstrom F, Zethraeus N et al (2008) Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden. Acta Orthop 79:269–280. doi:10.1080/17453670710015094 CrossRefPubMed

12.

Borgström F, Zethraeus N, Johnell O et al (2006) Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int 17:637–650. doi:10.1007/s00198-005-0015-8 CrossRefPubMed

13.

Rice DP (2000) Cost of illness studies: what is good about them? Inj Prev 6:177–179. doi:10.1136/ip.6.3.177 CrossRefPubMedPubMedCentral

14.

OECD Data. https://data.oecd.org/. Accessed 8 Jan 2016

15.

(2014) Estonian health insurance fund annual report. https://www.haigekassa.ee/sites/default/files/uuringud_aruanded/haigekassa_aastaraamat_2014_eng.pdf

16.

Jürisson M, Vorobjov S, Kallikorm R et al (2015) The incidence of hip fractures in Estonia, 2005-2012. Osteoporos Int 26:77–84. doi:10.1007/s00198-014-2820-4 CrossRefPubMed

17.

EuroQol. http://www.euroqol.org/about-eq-5d.html. Accessed 13 Jul 2015

18.

Estonian Health Insurance Fund. http://www.haigekassa.ee/. Accessed 15 Jul 2015

19.

Dolan P (1997) Modeling valuations for EuroQol health States. Med Care 35:1095–1108CrossRefPubMed

20.

Walters SJ (2009) Quality of life outcomes in clinical trials and health-care evaluation: a practical guide to analysis and interpretation. John Wiley & Sons

21.

Human Mortality Database. http://www.mortality.org/. Accessed 11 Feb 2016

22.

Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383. doi:10.1016/0021-9681(87)90171-8 CrossRefPubMed

23.

Quan H, Sundararajan V, Halfon P et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130–1139CrossRefPubMed

24.

Quan H, Li B, Couris CM et al (2011) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173:676–682. doi:10.1093/aje/kwq433 CrossRefPubMed

25.

Toson B, Harvey LA, Close JCT (2015) The ICD-10 Charlson Comorbidity Index predicted mortality but not resource utilization following hip fracture. J Clin Epidemiol 68:44–51. doi:10.1016/j.jclinepi.2014.09.017 CrossRefPubMed

26.

Tan-Torres Edejer T, Baltussen R, Adam T, et al. (2003) Making choices in health: WHO guide to cost-effectivess analysis.

27.

Ministry of Social Affairs. http://www.sm.ee/en. Accessed 23 Jul 2015

28.

City of Tallinn. http://www.tallinn.ee/eng/. Accessed 23 Jul 2015

29.

Drummond MF (2005) Methods for the economic evaluation of health care programmes. Oxford University Press

30.

Statistics Estonia / Statistikaamet. http://www.stat.ee/. Accessed 5 Feb 2016

31.

World (WHO 2000-2025) Standard - Standard Populations - SEER Datasets. http://seer.cancer.gov/stdpopulations/world.who.html. Accessed 2 Jul 2015

32.

Si L, Winzenberg TM, de Graaff B, Palmer AJ (2014) A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions. Osteoporos Int. doi:10.1007/s00198-014-2636-2

33.

Ström O, Borgström F, Kanis JA et al (2011) Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 6:59–155. doi:10.1007/s11657-011-0060-1 CrossRefPubMed

34.

Dzajkovska B, Wertheimer AI, Mrhar A (2007) The burden-of-illness study on osteoporosis in the Slovenian female population. Pharm World Sci 29:404–411. doi:10.1007/s11096-007-9091-5 CrossRefPubMed

35.

Kudrna K, Krska Z (2005) Expense analysis of the proximal femoral fractures treatment. Rozhl Chir 84:631–634PubMed

36.

Stevenson M, Davis S, Kanis J (2006) The hospitalisation costs and out-patient costs of fragility fractures. Women’s Heal Med 3:149–151. doi:10.1383/wohm.2006.3.4.149 CrossRef

37.

Lawrence TM, White CT, Wenn R, Moran CG (2005) The current hospital costs of treating hip fractures. Injury 36:88–91. doi:10.1016/j.injury.2004.06.015, discussion 92CrossRefPubMed

38.

Nurmi I, Narinen A, Lüthje P, Tanninen S (2003) Cost analysis of hip fracture treatment among the elderly for the public health services: a 1-year prospective study in 106 consecutive patients. Arch Orthop Trauma Surg 123:551–554. doi:10.1007/s00402-003-0583-z CrossRefPubMed

39.

Ohsfeldt RL, Borisov NN, Sheer RL (2006) Fragility fracture-related direct medical costs in the first year following a nonvertebral fracture in a managed care setting. Osteoporos Int 17:252–258. doi:10.1007/s00198-005-1993-2 CrossRefPubMed

40.

Dimai HP, Redlich K, Peretz M et al (2012) Economic burden of osteoporotic fractures in Austria. Health Econ Rev 2:12. doi:10.1186/2191-1991-2-12 CrossRefPubMedPubMedCentral

41.

Larg A, Moss JR (2011) Cost-of-illness studies: a guide to critical evaluation. Pharmacoeconomics 29:653–671. doi:10.2165/11588380-000000000-00000 CrossRefPubMed

42.

The World Bank Group (2015) The State of health care integration in Estonia

43.

Knies S, Evers SMAA, Candel MJJM et al (2009) Utilities of the EQ-5D: transferable or not? Pharmacoeconomics 27:767–779. doi:10.2165/11314120-000000000-00000 CrossRefPubMed

Title: Quality of life, resource use, and costs related to hip fracture in Estonia
Authors: M. Jürisson
H. Pisarev
J. Kanis
F. Borgström
A. Svedbom
R. Kallikorm
M. Lember
A. Uusküla
Publication date: 01-08-2016
Publisher: Springer London
Published in: Osteoporosis International / Issue 8/2016
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-016-3544-4

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Quality of life, resource use, and costs related to hip fracture in Estonia

Abstract

Summary

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2016

Variations in fat mass contribution to bone mineral density by gender, age, and body mass index: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008–2011

Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis

Uncertain effects of calcium and vitamin D supplementation on fracture risk reduction

Young adults with cystic fibrosis have altered trabecular microstructure by ITS-based morphological analysis

Erratum and additional analyses re: Calcium plus vitamin D supplementation and the risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation

Vertebral body morphology is associated with incident lumbar vertebral fracture in postmenopausal women. The OFELY study